1-20 of 28
Marta Riva
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Overall Survival Among Luspatercept Responders and Predictors of Response

Angela Consagra, Luca Lanino, Najla H Al Ali, Luis E. Aguirre, Zhuoer Xie, Onyee Chan, Gloria Andreossi, Luca Rigodanza, Alessandro Sanna, Marco Gabriele Raddi, Alison R. Walker, Andrew T. Kuykendall, Jeffrey Lancet, Eric Padron, David A Sallman, Francesco Restuccia, Alessandra Perego, Marta Ubezio, Bruno Fattizzo, Marta Riva, Alessia Campagna, Matteo Giovanni Della Porta, Valeria Santini, Rami S. Komrokji
Journal: Blood
Blood (2023) 142 (Supplement 1): 1871.
https://doi.org/10.1182/blood-2023-186279
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Benedetta Cambò, Anna Lina Piccioni, Vincenzo Federico, Gianluca Cristiano, Elisabetta Lugli, Lorenzo Rizzo, Michelina Santopietro, Carla Mazzone, Massimiliano Bonifacio, Raffaele Palmieri, Antonella Poloni, Annalisa Biagi, Gianni Binotto, Marzia Delfina, Mario Annunziata, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Ambra Di Veroli, Pasquale Niscola, Marta Riva, Isabella Capodanno, Antonio Curti, Nicola Di Rienzo, Susanna Fenu, Monica Crugnola
Journal: Blood
Blood (2023) 142 (Supplement 1): 6497.
https://doi.org/10.1182/blood-2023-186085
Published: 2023
Journal Articles

SIE/Sies/GITMO Criteria in Elderly Patients with Acute Myeloid Leukemia (AML): Useful Also in the New Drug Era? a Multicentric Real-Life Study By the Hematological Network Rete Ematologica Lombarda (REL)

Erika Borlenghi, Lorenzo Masina, Marco Frigeni, Ivana Lotesoriere, Alfredo Molteni, Monica Fumagalli, Marta Riva, Patrizia Zappasodi, Massimo Bernardi, Nicola Fracchiolla, Federica Gigli, Claudia Basilico, Chiara Pagani, Federico Lussana, Paola Perfetti, Chiara Cattaneo, Monica Tajana, Silvia Viola, Gianluca Martini, Gloria Catalano, Mariarita Sciumè, Annalisa Condorelli, Giselda Cela, Giuseppe Rossi, Alessandra Tucci, Roberto Cairoli, Elisabetta Todisco
Journal: Blood
Blood (2023) 142 (Supplement 1): 956.
https://doi.org/10.1182/blood-2023-180568
Published: 2023
Journal Articles

Association of Hypomethylating Agents + Venetoclax in the Real-Life Treatment of Myeloproliferative Neoplasms in Blastic Phase

Roberto Latagliata, Gianluca Cristiano, Dorela Lame, Alda Strazimiri, Fabrizio Cavalca, Lorenzo Rizzo, Giulia De Luca, Simone Zoletto, Vincenzo Federico, Daniele Cattaneo, Annalisa Biagi, Monica Crugnola, Pasquale Niscola, Raffaele Palmieri, Anna Lina Piccioni, Olga Mulas, Beatrice Esposito Vangone, Michelina Santopietro, Ida Carmosino, Alessandra Iurlo, Nicola Di Rienzo, Gianni Binotto, Prassede Salutari, Marta Riva, Massimiliano Bonifacio, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2023) 142 (Supplement 1): 1842.
https://doi.org/10.1182/blood-2023-190091
Published: 2023
Journal Articles

Multiparametric Flow Cytometry-MRD Assay: Lesson from Phase II Trail REL AML 001

Arianna Gatti, Silvio Veronese, Giovanni Grillo, Barbara Di Camillo, Monica Fumagalli, Mauro Krampera, Patrizia Zappasodi, Erika Borlenghi, Elisabetta Todisco, Marta Ubezio, Massimo Bernardi, Alfredo Molteni, Claudia Basilico, Mauro Turrini, Rosa Greco, Valentina Mancini, Marta Riva, Gabriele Magliano, Marta Rachele Stefanucci, Bruno Brando, Alessandro Beghini, Roberto Cairoli
Journal: Blood
Blood (2023) 142 (Supplement 1): 5997.
https://doi.org/10.1182/blood-2023-185555
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Gianluca Cristiano, Dorela Lama, Susanna Fenu, Lorenzo Rizzo, Benedetta Cambò, Simone Zoletto, Francesca Spirito, Fabrizio Cavalca, Daniele Cattaneo, Natalia Cenfra, Giulia De Luca, Beatrice Esposito Vangone, Ambra Di Veroli, Raffaele Palmieri, Mario Annunziata, Olga Mulas, Elisabetta Abruzzese, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Prassede Salutari, Annalisa Biagi, Monica Bocchia, Michelina Santopietro, Gianni Binotto, Alessandra Iurlo, Monica Crugnola, Marta Riva, Anna Lina Piccioni, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2022) 140 (Supplement 1): 6176–6178.
https://doi.org/10.1182/blood-2022-167334
Published: 2022
Journal Articles

Evolutionary Portrait of Adult Core-Binding Factor Leukemia Patients Treated with a Continuation Therapy with Midostaurin: Preliminary Results

Roberto Cairoli, Arianna Gatti, Giovanni Grillo, Monica Fumagalli, Mauro Krampera, Patrizia Zappasodi, Erika Borlenghi, Elisabetta Todisco, Marta Ubezio, Massimo Bernardi, Alfredo Molteni, Claudia Basilico, Mauro Turrini, Rosa Greco, Valentina Mancini, Marta Riva, Beatrice De Marco, Marta Rachele Stefanucci, Bruno Brando, Silvio Marco Veronese, Alessandro Beghini
Journal: Blood
Blood (2022) 140 (Supplement 1): 9054–9056.
https://doi.org/10.1182/blood-2022-160024
Published: 2022
Journal Articles

Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes

Elisabetta Sauta, Marie Robin, Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Lin-Pierre Zhao, Juan Carlos Caballero Berrocal, Giulia Maggioni, Cristina Astrid Tentori, Massimo Bernardi, Carmen Di Grazia, Luca Vago, Giulia Rivoli, Lorenza Borin, Saverio D'Amico, Marta Ubezio, Alessia Campagna, Antonio Russo, Daniele Mannina, Luca Lanino, Patrizia Chiusolo, Luisa Giaccone, Maria Teresa Voso, Marta Riva, Esther Natalie Oliva, Matteo Zampini, Elena Riva, Olivier Nibourel, Claudia Sala, Marilena Bicchieri, Niccolò Bolli, Alessandro Rambaldi, Francesco Passamonti, Victor Savevski, Armando Santoro, Ulrich Germing, Shahram Kordasti, Valeria Santini, Maria Diez-Campelo, Guillermo Sanz, Francesc Solé, Wolfgang Kern, Uwe Platzbecker, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Castellani Gastone, Matteo G. Della Porta
Journal: Blood
Blood (2022) 140 (Supplement 1): 1121–1124.
https://doi.org/10.1182/blood-2022-163634
Published: 2022
Journal Articles

Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study

Alessandro Bosi, Bruno Fattizzo, Lorenzo Rizzo, Silvia Ferrari, Federico Lussana, Lorenza Maria Borin, Andrea Castelli, Paola Bianchi, Wilma Barcellini, Roberto Cairoli, Alfredo Molteni, Marta Riva
Journal: Blood
Blood (2022) 140 (Supplement 1): 6925–6926.
https://doi.org/10.1182/blood-2022-157430
Published: 2022
Journal Articles

Efficacy and Safety of Luspatercept in Adult Patients with Transfusion-Dependent Anemia Due to Very Low, Low and Intermediate Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts, Who Had an Unsatisfactory Response to or Are Ineligible for Erythropoietin-Based Therapy: A Retrospective Multicenter Study By Fondazione Italiana Sindromi Mielodisplastiche (FiSiM ETS)

Luca Lanino, Prassede Salutari, Alessandra Perego, Bruno Fattizzo, Marta Riva, Marta Ubezio, Pellegrino Musto, Daniela Cilloni, Esther Natalie Oliva, Maria Teresa Voso, Anna Maria Pelizzari, Antonella Poloni, Isabella Capodanno, Chiara Elena, Claudio Fozza, Fabrizio Pane, Massimo Breccia, Marco De Gobbi, Francesco Di Bassiano, Daniela Barraco, Elena Crisà, Dario Ferrero, Chiara Frairia, Antonella Vaccarino, Davide Griguolo, Stefania Paolini, Martina Quintini, Mariarosaria Sessa, Mauro Turrini, Monica Bocchia, Nicola Di Renzo, Elisa Diral, Cristina Foli, Alfredo Molteni, Ubaldo Occhini, Giulia Rivoli, Carmine Selleri, Roberto Bono, Anna Calvisi, Andrea Castelli, Eros Di Bona, Ambra Di Veroli, Luana Fianchi, Sara Galimberti, Daniele Grimaldi, Monia Marchetti, Marianna Norata, Alessandro Rambaldi, Ilaria Tanasi, Patrizia Tosi, Ilaria Naldi, Valeria Santini, Matteo G. Della Porta
Journal: Blood
Blood (2022) 140 (Supplement 1): 6945–6948.
https://doi.org/10.1182/blood-2022-164559
Published: 2022
Journal Articles

Luspatercept in Combination with Recombinant-Erythropoietin in MDS RS Patients: Stimulating Early and Late Erythropoiesis

Francesco Versino, Marta Bortolotti, Beatrice Ferrari, Lorenzo Rizzo, Federico Mazzon, Marta Riva, Paola Bianchi, Wilma Barcellini, Bruno Fattizzo
Journal: Blood
Blood (2022) 140 (Supplement 1): 12323–12324.
https://doi.org/10.1182/blood-2022-158279
Published: 2022
Journal Articles

Luspatercept in MDS with Ring Sideroblasts: A Real-Life Multicenter Experience from a Named Patient Program

Marta Riva, Bruno Fattizzo, Lorenzo Rizzo, Federico Mazzon, Juri Alessandro Giannotta, Wilma Barcellini, Roberto Cairoli
Journal: Blood
Blood (2021) 138 (Supplement 1): 4659.
https://doi.org/10.1182/blood-2021-153179
Published: 2021
Journal Articles

NGS Evaluation of the Eqol-MDS Trial: Preliminary Analysis of Eltrombopag for Thrombocytopenia of Low-Risk MDS

Esther Natalie Oliva, Corrado Mammi', Maria Cuzzola, Yasuhito Nannya, Austin G. Kulasekararaj, Maria Grazia D'Errigo, Maria Concetta Cannatà, Gina Zini, Roberto Latagliata, Pasquale Niscola, Valeria Santini, Marta Riva, Isabella Capodanno, Sabrina Greve, Alexander E Smith, Seishi Ogawa
Journal: Blood
Blood (2021) 138 (Supplement 1): 1516.
https://doi.org/10.1182/blood-2021-150619
Published: 2021
Journal Articles

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Marta Riva, Lorenzo Rizzo, MD, Valentina Mancini, MD, Rosa Greco, MD, Giambattista Bertani, MD, Elisa Zucchetti, MD, Elisa Diral, MD, Michele Nichelatti, PhD, Silvio Marco Veronese, Giovanni Grillo, MD, Roberto Cairoli
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141987
Published: 2020
Journal Articles

Prospective Evaluation of a Continuation Therapy with Midostaurin in Adult Patients with Core-Binding Factor Leukemia and Integrated Genetic Analysis: A Multi Center Phase II Study. Preliminary Results

Roberto Cairoli, Mauro Krampera, MD PhD, Patrizia Zappasodi, MD, Elisabetta Todisco, MDPhD, Erika Borlenghi, MD, Alfredo Molteni, MD, Monica Fumagalli, MD, Marta Ubezio, Massimo Bernardi, MD, Rosa Greco, MD, Erika Ravelli, MD, Valentina Mancini, MD, Giovanni Grillo, MD, Marta Riva, Beatrice De Marco, Adriana Cassaro, PhD, Bruno Brando, MD, Arianna Gatti, Silvio Marco Veronese, Alessandro Beghini
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137092
Published: 2020
Journal Articles

A Multicenter, Italian Trial of Early Iron Chelation Therapy with Low Dose Deferasirox (Exjade®) in Patients with Low/Intermediate-1 Risk MDS at the Beginning of Transfusional Story

Emanuele Angelucci, MD, Mario Capasso, PhD, Matteo Giovanni Della Porta, MD, Gian Luca Forni, Domenico Girelli, MD, PhD, Esther Natalie Oliva, MD, Federica Pilo, MD, Marino Clavio, MD, Marta Riva, MD, Annamaria Pelizzari, MD, Pasquale Niscola, MD PhD, Daniela Cilloni, MD PhD, Gianni Binotto, MD, Elena Crisà, MD, Valeria Santini, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4256.
https://doi.org/10.1182/blood-2019-125575
Published: 2019
Journal Articles

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Esther Natalie Oliva, MD, Caterina Alati, MD, Valeria Santini, MD, Antonella Poloni, PhD MD, Marta Riva, MD, Pasquale Niscola, MD PhD, Valentina Giai, MD, Grazia Sanpaolo, MD, Enrico Balleari, Elena Crisà, MD, Dario Ferrero, MD, Ulrich Germing, MD, Pierre Fenaux, MD PhD, Giuseppe A. Palumbo, MD PhD, Prassede Salutari, MD, Stefana Impera, MD, Isabella Capodanno, MD, Gianluigi Reda, MD, Anna Marina Liberati, Alfredo Molteni, MD, Giorgina Specchia, MD, Francesco Buccisano, MD, Maria Teresa Voso, MD, Stefano Mancini, MD, Monica Bocchia, Anna Candoni, MD, Bruno Martino, MD, Patrizia Cufari, Maria Grazia D'Errigo, Gina Zini, MD PhD, Roberto Latagliata
Journal: Blood
Blood (2019) 134 (Supplement_1): 3000.
https://doi.org/10.1182/blood-2019-126744
Published: 2019
Journal Articles

Clinical Relevance of Individual Response to Iron Chelation Therapy (ICT) in Patients with Myelodysplastic Syndromes (MDS) and Transfusion Requirement

Roberto Latagliata, Pasquale Niscola, MD PhD, Esther Natalie Oliva, MD, Marta Riva, MD, Isabella Capodanno, MD, Antonio Volpe, MD, Federica Pilo, MD, Claudia Baratè, Alessia Campagna, MD, Anna Maria Pelizzari, Antonella Poloni, PhD MD, Chiara Sarlo, MD, Giovanna Mansueto, Anna Lina Piccioni, Serena Rosati, MD, Ida Carmosino, Antonella Carbone, MD, Lucia Tognazzi, Prassede Salutari, MD, Annalisa Mancini, Patrizia Cuffari, Elsa Pennese, MD, Susanna Fenu, Maria Antonietta Aloe Spiriti, MD, Sara Galimberti, MD PhD, Alfredo Molteni, MD, Enrico Balleari, Massimo Breccia, MD, Robin Foà, MD, Luca Maurillo, Carlo Finelli
Journal: Blood
Blood (2019) 134 (Supplement_1): 3010.
https://doi.org/10.1182/blood-2019-129902
Published: 2019
Journal Articles

Danazol Treatment for Thrombocytopenia in Lower-Risk Myelodysplastic Syndromes: A Pilot Real Life Experience

Marta Riva, Lara Crucitti, Emanuele Ravano, MD, Michele Nichelatti, PhD, Gianluigi Reda, MD, Cristina Fiamenghi, Roberto Cairoli, Alfredo Molteni, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4375.
https://doi.org/10.1182/blood-2018-99-115283
Published: 2018
Journal Articles

P53 and CD34 Immunohistochemical Expression on Bone Marrow Biopsy As Predictive Marker of Response to Erythropoietin in Low Risk Myelodysplastic Syndrome

Gianluigi Reda, MD, Francesca Boggio, Sr., MD, Ramona Cassin, MD, Marta Riva, Marco Barella, MD, Alessandro del Gobbo, MD, Laura Bandiera, Emanuela Bonoldi, Alfredo Molteni, MD, Agostino Cortelezzi, MD, Umberto Gianelli, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5511.
https://doi.org/10.1182/blood-2018-99-118811
Published: 2018